Literature DB >> 33039175

Reconsidering α-Blockade for the Management of Hypertension in Patients With CKD.

Sarah Ahmad1, Adam Neubauer2, Jordana B Cohen3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33039175      PMCID： PMC7886005          DOI： 10.1053/j.ajkd.2020.08.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  14 in total

1.  Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.

Authors:  M Chung; V Vashi; J Puente; M Sweeney; P Meredith
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 2.  A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2008-05-30       Impact factor: 2.373

Review 3.  Hypertension in CKD: Core Curriculum 2019.

Authors:  Elaine Ku; Benjamin J Lee; Jenny Wei; Matthew R Weir
Journal:  Am J Kidney Dis       Date:  2019-03-19       Impact factor: 8.860

Review 4.  Neurohormonal activation in heart failure with reduced ejection fraction.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2016-10-06       Impact factor: 32.419

Review 5.  Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?

Authors:  Neil Chapman; Chung-Yin Chen; Toshiro Fujita; F D Richard Hobbs; Soo-Joong Kim; Jan A Staessen; Supachai Tanomsup; Ji-Guang Wang; Bryan Williams
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

6.  Alpha-Blocker Use and the Risk of Hypotension and Hypotension-Related Clinical Events in Women of Advanced Age.

Authors:  Swapnil Hiremath; Marcel Ruzicka; William Petrcich; Megan K McCallum; Gregory L Hundemer; Peter Tanuseputro; Douglas Manuel; Kevin Burns; Cedric Edwards; Ann Bugeja; Peter Magner; Brendan McCormick; Amit X Garg; Emily Rhodes; Manish M Sood
Journal:  Hypertension       Date:  2019-07-22       Impact factor: 10.190

7.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  Prevalence of refractory hypertension in the United States from 1999 to 2014.

Authors:  Michael G Buhnerkempe; Albert Botchway; Vivek Prakash; Mohammad Al-Akchar; Carlos E Nolasco Morales; David A Calhoun; John M Flack
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

9.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

Review 10.  Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.

Authors:  Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2018-07-06       Impact factor: 4.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.